Patent AnalyticsExaminers
Rankings

Company or institution

ONCOTHERAPY SCIENCE, INC.

186 applicationsfiled 2006 to 2026

Allowance rate
63%
−12 pts vs the USPTO range 56% to 70%
Rejections before allowance
1.4
−0.2 vs the USPTO
Months to first action
15.8 mo
−2.8 vs the USPTO
Needed an RCE
23%
−4 pts vs the USPTO

Timeline

Applications by filing year: drag across the years to study a period

Allowed in green, abandoned in red, pending in grey. The figures above and the charts that can be recomputed by filing year follow the span you pick.

Compared with the office

Against every applicant before the USPTO

Unlock the comparison with the officeFree with an account. No card needed.

Create a free account

Trend

Allowance by filing year

Unlock the trendIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Domains

Where the applications fall

CPC subclasses

A61K Medical preparations62 apps
C07K Peptides53 apps
C12Q Measuring or testing processes involving enzymes or nucleic acids24 apps
G01N Investigating or analysing materials21 apps
C12N Microorganisms or enzymes13 apps
C07D Heterocyclic compounds6 apps

Art units

164358 apps
164238 apps
164615 apps
164414 apps
163511 apps
164710 apps

Who represents them

Law firms and agents on their applications

Bars show the share of decided applications that were allowed.

Unlock the firms on their applicationsIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Rejection fingerprint

What gets rejected, by statute

Share of parsed office actions raising each ground; blue is the USPTO.

Unlock the rejection fingerprintIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

What works

Allowance by strategy used

Unlock what works for this filerIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Interviews

Does an interview help?

Unlock the interview figuresFree with an account. No card needed.

Create a free account

Applications

Every application in the record

ApplicationTitleFiledStatusRejectionsRCEsTo 1st action
19546792THERAPEUTIC AGENT FOR BREAST CANCER COMPRISING BIG3-PHB2 INTERACTION-INHIBITING PEP…2026-02-23Pending00n/a
19546921THERAPEUTIC AGENT FOR BREAST CANCER COMPRISING BIG3-PHB2 INTERACTION-INHIBITING PEP…2026-02-23Pending00n/a
18094167CDCA1-DERIVED PEPTIDE AND VACCINE CONTAINING SAME2023-01-06Allowed218.1 mo
15317298Method and apparatus for adaptive signal processing2012-01-10Allowed1012.0 mo
15447078Composition and method for controlled release2015-02-11Abandoned4123.0 mo
15558993Distributed ledger transaction verification2018-03-12Allowed3020.0 mo
15422291Thermal management of battery assemblies2021-04-13Pending2117.0 mo
15859243Machine learning model for anomaly detection2012-05-14Allowed1014.0 mo
15789866Wireless power transfer coil arrangement2015-06-15Abandoned4125.0 mo
15191331Catalyst for selective hydrogenation2018-07-16Allowed3022.0 mo
Unlock all 186 applications, each with its full timelineIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in